Generation Bio Co.

Generation Bio Co. pioneers in vivo T‑cell reprogramming via cell‑targeted lipid nanoparticles, unlocking high‑value, historically druggable genes for rare autoimmune and retinal diseases.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 115
HQ: Cambridge

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
GBIO	Generation Bio Co. Cap: 0.0B	EQUITY	NMS	USD	US37148K1007	Active	📈